Beta Bionics Announces iLet Bionic Pancreas Is Now Added to the Express Scripts National Commercial Formularies
Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced that effective November 10th, Express Scripts has added the iLet...
Groundbreaking Study Reveals the Effectiveness of New RecoSMA Laser Treatment for Diabetic Foot
A recent study published in the Journal of Wound Care (UK) has shed light on a revolutionary approach to diabetic foot care that promises hope...
Seraxis Announces Publication of Preclinical Data for a Novel Islet Replacement Therapy and Clinical Candidate SR-02 for Insulin-Requiring Diabetes; Oral Presentation at IPITA
Manuscript describes the unique character of a pancreatic endocrine cell population derived from a non-pluripotent stem cell that closely resembles native islets in composition and...
Seraxis to Provide Oral Update on Its Pancreatic Organoid Candidate for Functional Cure of T1D at the 59th Annual Meeting of the EASD
Dr. William Rust will give an oral presentation on Seraxis’ proprietary technology for the production of therapeutic pancreatic organoids from pancreas-derived stem cells, as well...
Seraxis Announces Closing of Second VC Tranche and Successful Completion of Preclinical Studies of Pancreatic Organoids From Seraxis’ Novel Pancreas-Derived Stem Cells
Leadership team expanded with addition of Chief Corporate Development Officer, Ted Hibben, a 25-year venture-stage business development biotherapeutic industry veteran Total venture funding tops $50M...
AQ Pharmaceuticals, Inc. Announces Results of JBA Brands GlucoTrojan (R) Study: Findings Show Reduction in Sugar Absorption
Affordable Quality Pharmaceuticals (AQP), established in 2000, has developed a powder supplement, GlucoTrojan, indicating to "reduce the absorption of sugars and carbs up to 40...
Seraxis Presents Successful Results Using Synthetic Replacement Endocrine Clusters for Type 1 Diabetes at the 4th IPITA / HSCI / JDRF Summit
Seraxis Inc., a pre-clinical stage company with a best-in-class islet replacement therapy for insulin-dependent diabetes, today announced the presentation of results from an efficacy study...
NHS Hospital Trust Pilot of New Testing Technology Sees Pregnant Women in Southampton Become the First Patients Globally to Access Gestational Diabetes Testing at Home
UHS Partners with Digostics to Launch the World's First Home Testing Service for Gestational DiabetesOXFORD, UK / ACCESSWIRE / April 19, 2023 / Digital clinical...
Medtronic LABS’ Broader Scope Expands Access
NORTHAMPTON, MA / ACCESSWIRE / April 7, 2023 / Medtronic:World Health Day is celebrated each year on April 7 and marks the anniversary of the...
New Study in Experimental Biology and Medicine Shows the Role of Sphingosine Kinase 2 as Therapeutic Target for Diabetes
A recently published article in Experimental Biology and Medicine (Volume 248, Issue 1, January 2023) provides a mechanism by which Sphingosine kinase 2 (ShK2) impacts Insulin...